Return to news index

Prohibited substance cases under FEI anti-doping rules

The FEI has announced two adverse analytical findings involving prohibited substances.
The cases involve the use of Ractopamine, and O-Desmethyltramadol, a metabolite of Tramadol which are *Banned Substances under the FEI's Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).

Horse: HSM Cornelio (FEI ID 104GP38/COL)
Person Responsible: Pablo Carreño Mora (FEI ID 10072192 /COL)
Event: CEI1* 80 - Ubate (COL), 19-20.08.2017
Prohibited Substance: Ractopamine
Date of notification (7 November 2017)

Horse: Saura De Fondcombe (FEI ID 103CM83/SUI)
Person Responsible: Nadja Peter Steiner (FEI ID 10006562/SUI)
Event: CSI3*-W - Tetouan (MAR) 05-08.10.2017
Prohibited Substance: O-Desmethyltramadol
Date of notification (9 November 2017)

The athletes listed have been provisionally suspended from the date of notification until the FEI Tribunal renders a decision. The horses, also listed, have been provisionally suspended for two months:

Details on these cases can be found here.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now